Increased Risk of Migraine Among Patients with HS: A US Multi-Center Cohort Study

Increased Risk of Migraine Among Patients with HS: A US Multi-Center Cohort Study

Summary Verified By: Chi Ching-Chi, Ph.D. | School of Medicine, College of Medicine, Chang Gung University, Taiwan

June 1, 2025

This plain-language research summary was generated by AI, courtesy of HS Simplified.

Increased Risk of Migraine Among Patients with HS: A US Multi-Center Cohort Study

Patients with hidradenitis suppurativa (HS) face a heightened risk of developing migraines, according to a 2025 study. HS, a chronic skin condition causing painful abscesses and inflammation, shares inflammatory pathways with migraines, a condition characterized by severe headaches. Understanding these connections may aid in better management of both conditions.

Researchers have uncovered an important link between hidradenitis suppurativa (HS) and migraine. HS is a chronic skin condition known for causing painful lumps and inflammation. This study suggests that people with HS might be at greater risk of developing migraines. This finding is significant because both HS and migraines are challenging conditions that affect quality of life.

Why Explore the Link Between HS and Migraines?

Both HS and migraines involve inflammation and share common pathways in the body. Understanding their connection could lead to better management strategies for patients who suffer from both conditions.

Study Design and Approach

This study used data from the TriNetX Research Network, which collects electronic health records from multiple U.S. healthcare centers. Researchers compared 105,171 patients with HS to an equal number of controls without HS. They matched these groups based on factors like age, gender, and lifestyle to ensure fair comparisons. The main focus was to see if having HS increased the risk of newly developing migraine.

Key Findings

Patients with HS had a 35% higher risk of developing migraines compared to those without HS. Specifically, the risk of migraine with aura was 36% higher, and migraine without aura was 31% higher. Women with HS showed an even greater risk, with a 38% increase compared to women without HS.

Understanding the Implications

This research highlights the importance for doctors to be aware of the increased migraine risk in HS patients. Recognizing this link can lead to earlier interventions and better management of both conditions, potentially improving patient outcomes.

Study Limitations

While this study provides valuable insights, there are some limitations. It mainly included data from people who sought medical care, which may not represent everyone with HS. Also, the study couldn't definitively prove that HS causes migraines—only that there's a strong association. Other factors like genetics or lifestyle weren't fully explored, which could also influence the results.

In conclusion, this study emphasizes the need for healthcare providers to consider the potential for migraines in patients with HS. Early recognition and treatment of migraines in these patients could make a significant difference in their quality of life.

Read the original paper

Author(s)

Shuo-Yan Gau, Shao-Wei Lo, Tsu-Man Chiu, Chen-Pi Li, Ru-Yin Tsai, Hui-Chin Chang, Ching-Chi Chi

Stay connected with the latest news, research updates, and community stories from the HS Foundation.

Sign up for our email newsletter